Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Schipper

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
The Lancet. Oncology|November 17, 2024
Effectiveness and safety of immune checkpoint inhibitors in Black patients versus White patients in a US national health system: a retrospective cohort studySean Miller, Ralph Jiang, Matthew Schipper, et al.
JNCI Cancer Spectrum|April 24, 2026
Understanding randomized controlled trial generalizability through an embedded molecular diagnostics trialPatrick Lewicki, Arnav Srivastava, Ralph Jiang, et al.
International Journal of Radiation Oncology, Biology, Physics|July 27, 2021
Predictors of Pneumonitis After Conventionally Fractionated Radiotherapy for Locally Advanced Lung CancerMatthew R McFarlane, Kimberly A Hochstedler, Anna M Laucis, et al.
Cancer|June 10, 2024
Impact of lung cancer screening on stage migration and mortality among the national Veterans Health Administration population with lung cancerDonna M Edwards, Mina Pirzadeh, Tony Van, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 16, 2025
Impact of PSMA PET Staging on Initial Treatment in Newly Diagnosed Prostate CancerSean R Miller, Dana H Chung, Rachel T Gonzalez, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 3, 2025
Rates of PSMA PET Staging and Positivity in Newly Diagnosed Prostate Cancer in a National Health Care SystemSean R Miller, Rachel Tucker Gonzalez, William C Jackson, et al.
Prostate Cancer and Prostatic Diseases|July 21, 2021
Impact of Decipher Biopsy testing on clinical outcomes in localized prostate cancer in a prospective statewide collaborativeRandy A Vince, Ralph Jiang, Ji Qi, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2020
BRAINSTORM: A Multi-Institutional Phase 1/2 Study of RRx-001 in Combination With Whole Brain Radiation Therapy for Patients With Brain MetastasesMichelle M Kim, Hemant A Parmar, Matthew Schipper, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 2021
A Phase 2 Study of Dose-intensified Chemoradiation Using Biologically Based Target Volume Definition in Patients With Newly Diagnosed GlioblastomaMichelle M Kim, Yilun Sun, Madhava P Aryal, et al.
Practical Radiation Oncology|January 7, 2018
A multi-institutional phase 2 trial of prostate stereotactic body radiation therapy (SBRT) using continuous real-time evaluation of prostate motion with patient-reported quality of lifeWilliam C Jackson, Robert T Dess, Dale W Litzenberg, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
The Lancet. Oncology|November 17, 2024
Effectiveness and safety of immune checkpoint inhibitors in Black patients versus White patients in a US national health system: a retrospective cohort studySean Miller, Ralph Jiang, Matthew Schipper, et al.
JNCI Cancer Spectrum|April 24, 2026
Understanding randomized controlled trial generalizability through an embedded molecular diagnostics trialPatrick Lewicki, Arnav Srivastava, Ralph Jiang, et al.
International Journal of Radiation Oncology, Biology, Physics|July 27, 2021
Predictors of Pneumonitis After Conventionally Fractionated Radiotherapy for Locally Advanced Lung CancerMatthew R McFarlane, Kimberly A Hochstedler, Anna M Laucis, et al.
Cancer|June 10, 2024
Impact of lung cancer screening on stage migration and mortality among the national Veterans Health Administration population with lung cancerDonna M Edwards, Mina Pirzadeh, Tony Van, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 16, 2025
Impact of PSMA PET Staging on Initial Treatment in Newly Diagnosed Prostate CancerSean R Miller, Dana H Chung, Rachel T Gonzalez, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 3, 2025
Rates of PSMA PET Staging and Positivity in Newly Diagnosed Prostate Cancer in a National Health Care SystemSean R Miller, Rachel Tucker Gonzalez, William C Jackson, et al.
Prostate Cancer and Prostatic Diseases|July 21, 2021
Impact of Decipher Biopsy testing on clinical outcomes in localized prostate cancer in a prospective statewide collaborativeRandy A Vince, Ralph Jiang, Ji Qi, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2020
BRAINSTORM: A Multi-Institutional Phase 1/2 Study of RRx-001 in Combination With Whole Brain Radiation Therapy for Patients With Brain MetastasesMichelle M Kim, Hemant A Parmar, Matthew Schipper, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 2021
A Phase 2 Study of Dose-intensified Chemoradiation Using Biologically Based Target Volume Definition in Patients With Newly Diagnosed GlioblastomaMichelle M Kim, Yilun Sun, Madhava P Aryal, et al.
Practical Radiation Oncology|January 7, 2018
A multi-institutional phase 2 trial of prostate stereotactic body radiation therapy (SBRT) using continuous real-time evaluation of prostate motion with patient-reported quality of lifeWilliam C Jackson, Robert T Dess, Dale W Litzenberg, et al.
Pageof 9